ORIGINAL ARTICLE
A retrospective analysis of secondary malignancy development in nevus sebaceus
 
More details
Hide details
1
Department of Pathology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey
 
 
Submission date: 2025-06-17
 
 
Final revision date: 2025-10-02
 
 
Acceptance date: 2025-10-28
 
 
Publication date: 2025-12-19
 
 
Corresponding author
Fatma Seher Pehlivan
Assistant Professor Fatma Seher Pehlivan Department of Pathology Faculty of Medicine Manisa Celal Bayar University Hafsa Sultan Hospital Yunusemre, Manisa, Türkiye
 
 
Pol J Pathol 2025;76(3):233-238
 
KEYWORDS
TOPICS
ABSTRACT
Nevus sebaceous (NS) is a benign hamartomatous lesion; however, benign proliferative lesions are less frequently associated with secondary neoplasms. The aim of this study is to evaluate the prevalence of secondary benign and malignant tumours seen in NS lesions, and to reveal the histopathological features of these lesions.
Eighty-six NS cases were retrospectively evaluated for gender, age, lesion location, and accompanying lesions, as well as secondary benign and malignant tumours. The data obtained using descriptive statistics were analysed.
66.3% of cases were male, 33.7% were female, and the mean age was 37.8 years. 61.6% of lesions were localised on the face, 37.2% on the scalp, and 1.2% on the back. Secondary lesion development was observed in 39.5% of cases. The most common malignancy, as reported in the literature, was basal cell carcinoma. 
Although secondary lesions, secondary tumours, and malignancy development are rare in NS lesions, careful follow-up and surgical excision if necessary are recommended, especially in adulthood. This study contributes to the literature by revealing the pathological characteristics of secondary lesions accompanying NS, emphasising the need for careful histological evaluation of NS excisions in the differential diagnosis and raising awareness that malignancies may be present.
REFERENCES (19)
1.
Dowdle TS, Mehegran DA, Maldonado D, McCaughey CD. Multiple secondary neoplasms in nevus sebaceus excision. Proc (Bayl Univ Med Cent) 2021; 35: 241-242.
 
2.
Baigrie D, Troxell T, Cook C. Nevus sebaceus. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
 
3.
Lei T, Lu Y, Feng Y, Ni Y. Case report: basal cell carcinoma arising within the nevus sebaceous: report of 4 cases and literature review. Front Oncol 2025; 14: 1478747.
 
4.
Calonje JE, Brenn T, Lazar AJ, Billings SD. mckee’s pathology of the skin. 5th ed. Medipage, Warszawa 2019.
 
5.
Kamyab-Hesari K, Seirafi H, Jahan S, Aghazadeh N, Hejazi P, Azizpour A, et al. Sebaceous nevus: a clinicopathological study of 168 cases and review of the literature. Int J Dermatol 2016; 55: 193-200.
 
6.
Hsu MC, Liau JY, Hong JL, Cheng Y, Liao YH, Chen JS, et al. Secondary neoplasms arising from nevus sebaceus: a retrospective study of 450 cases in Taiwan. J Dermatol 2016; 43: 175-180.
 
7.
Idriss MH, Elston DM. Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases. J Am Acad Dermatol 2014; 70: 332-337.
 
8.
Aslam A, Salam A, Griffiths CE, McGrath JA. Sebaceous nevus: a mosaic RASopathy. Clin Exp Dermatol 2014; 39: 1-6.
 
9.
Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 2012; 44: 783-787.
 
10.
Kim YS, Park GS, Chung YJ, Lee JH. Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations. J Dermatol 2023; 50: 1072-1075.
 
11.
Ye Q, Wu Q, Jia M, Li FZ, Fang S. Secondary tumors arising from nevus sebaceus: a multicenter collaborative study and literature review. Dermatology 2023; 239: 140-147.
 
12.
Pang S, Cevik J, Sreedharan S, Wilks DJ. Rate of benign and malignant secondary tumors associated with nevus sebaceous: a systematic review and meta-analysis. Ann Plast Surg 2024; 92: 711-719.
 
13.
Silva Neto MP, de Assis BR, Andrade GR. Sebaceous nevus of Jadassohn: review and clinical-surgical approach. An Bras Dermatol 2022; 97: 628-636.
 
14.
Kong SH, Han SH, Kim JH, Oh YW, Park HJ, Suh HS, et al. Optimal timing for surgical excision of sebaceous nevus on the scalp: a single-center experience. Dermatol Surg 2020; 46: 20-25.
 
15.
Hashem R, Tynngård N, Lundmark K, Falk L. Microcystic adnexal carcinoma originating in a sebaceous nevus: a case report of a 16-year-old boy. Acta Derm Venereol 2019; 99: 1182-1183.
 
16.
Pepi C, de Palma L, Trivisano M, Pietrafusa N, Lepri FR, Diociaiuti A, et al. The role of KRAS mutations in cortical malformation and epilepsy surgery: a novel report of nevus sebaceous syndrome and review of the literature. Brain Sci 2021; 11: 793.
 
17.
Happle R. Nevus sebaceus is a mosaic RASopathy. J Invest Dermatol 2013; 133: 597-600.
 
18.
Pan C, Zhou X, Hong A, Fang F, Wang Y. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report. BMC Med Genomics 2020; 13: 188.
 
19.
Fernandes DA, Sang K, Sperling L. Sebaceous nevus with novel HRAS sequence variant mutation misdiagnosed as alopecia areata. Cutis 2023; 111: E30-E32.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top